Ensysce Biosciences (ENSCW) EBIAT (2020 - 2025)
Historic EBIAT for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to -$3.7 million.
- Ensysce Biosciences' EBIAT fell 66350.9% to -$3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.0 million, marking a year-over-year decrease of 3842.2%. This contributed to the annual value of -$8.0 million for FY2024, which is 2483.72% up from last year.
- Latest data reveals that Ensysce Biosciences reported EBIAT of -$3.7 million as of Q3 2025, which was down 66350.9% from -$1.7 million recorded in Q2 2025.
- Ensysce Biosciences' EBIAT's 5-year high stood at $661769.0 during Q3 2024, with a 5-year trough of -$17.2 million in Q3 2021.
- Moreover, its 5-year median value for EBIAT was -$2.7 million (2023), whereas its average is -$4.2 million.
- Its EBIAT has fluctuated over the past 5 years, first plummeted by 5482804.8% in 2021, then skyrocketed by 12459.37% in 2024.
- Ensysce Biosciences' EBIAT (Quarter) stood at -$10.0 million in 2021, then surged by 45.42% to -$5.5 million in 2022, then skyrocketed by 36.03% to -$3.5 million in 2023, then dropped by 1.71% to -$3.6 million in 2024, then dropped by 4.62% to -$3.7 million in 2025.
- Its last three reported values are -$3.7 million in Q3 2025, -$1.7 million for Q2 2025, and -$1.9 million during Q1 2025.